253 related articles for article (PubMed ID: 3942200)
1. Morphologic effects of bromocriptine on spontaneously occurring pituitary prolactin-cell hyperplasia in old Long-Evans rats.
McComb DJ; Hellmann P; Thorner MO; Scott D; Evans WS; Kovacs K
Am J Pathol; 1986 Jan; 122(1):7-16. PubMed ID: 3942200
[TBL] [Abstract][Full Text] [Related]
2. Spontaneous sparsely-granulated prolactin-producing pituitary adenomas in aging rats. A prospective study of the effect of bromocriptine.
McComb DJ; Hellmann P; Kovacs K; Scott D; Evans WS; Burdman JA; Thorner MO
Neuroendocrinology; 1985 Sep; 41(3):201-11. PubMed ID: 4047338
[TBL] [Abstract][Full Text] [Related]
3. Hyperprolactinemia after neonatal prolactin (PRL) deficiency in rats: evidence for altered anterior pituitary regulation of PRL secretion.
Shah GV; Shyr SW; Grosvenor CE; Crowley WR
Endocrinology; 1988 May; 122(5):1883-9. PubMed ID: 3129278
[TBL] [Abstract][Full Text] [Related]
4. Cytosuppressive effect of bromocriptine on human prolactinomas: stereological analysis of ultrastructural alterations with special reference to secretory granules.
Saitoh Y; Mori S; Arita N; Hayakawa T; Mogami H; Matsumoto K; Mori H
Cancer Res; 1986 Mar; 46(3):1507-12. PubMed ID: 3943108
[TBL] [Abstract][Full Text] [Related]
5. [Morphological studies on estrogen-induced PRL cell hyperplasia in rat pituitary gland--immunocytochemical and scanning electron microscopic studies].
Inagaki H; Hori T
No To Shinkei; 1989 Jun; 41(6):593-601. PubMed ID: 2803826
[TBL] [Abstract][Full Text] [Related]
6. Adenohypophysial dopamine content and prolactin secretion in the aged male and female rat.
Demarest KT; Moore KE; Riegle GD
Endocrinology; 1985 Apr; 116(4):1316-23. PubMed ID: 3971917
[TBL] [Abstract][Full Text] [Related]
7. Effects of bromocriptine on pituitary organelle marker enzyme activities in lactating and postlactating rats: selective activation of lysosomal prolactin proteolytic activity.
De Marco L; Mashiter K; Caughey B; Peters TJ
Endocrinology; 1984 Sep; 115(3):984-9. PubMed ID: 6086293
[TBL] [Abstract][Full Text] [Related]
8. Decreased prolactin level in secretory granules and their increased exocytosis in estrogen-induced pituitary hyperplasia in rats treated with a dopamine agonist.
Maeda T; Sawada K; Itoh Y; Moriwaki K; Mori H
Lab Invest; 1991 Dec; 65(6):679-87. PubMed ID: 1753713
[TBL] [Abstract][Full Text] [Related]
9. Age-related alterations in the number and function of pituitary lactotropic cells from intact and ovariectomized rats.
Chuknyiska RS; Blackman MR; Hymer WC; Roth GS
Endocrinology; 1986 May; 118(5):1856-62. PubMed ID: 3698899
[TBL] [Abstract][Full Text] [Related]
10. Hyperprolactinemia exerts a negative effect on the beta-endorphin content of the rat neurointermediate pituitary lobe.
Lamberts SW; Uitterlinden P; Bons EG; Zuiderwijk JM; Verleun T; Oosterom R; Hackeng WH
Endocrinology; 1984 Jun; 114(6):2349-53. PubMed ID: 6327244
[TBL] [Abstract][Full Text] [Related]
11. Fine structure of rat prolactin cells after treatment with a long acting depot contraceptive.
Aumüller G; Wagner R; Gräf KJ
Acta Endocrinol (Copenh); 1978 Oct; 89(2):251-62. PubMed ID: 696178
[TBL] [Abstract][Full Text] [Related]
12. Ultrastructural and immunocytochemical studies of prolactin-secreting cells (PRL cells) in the anterior pituitary gland of the female musk shrew (Suncus murinus L.).
Ishibashi T; Shiino M
Anat Rec; 1988 Apr; 220(4):415-23. PubMed ID: 3382031
[TBL] [Abstract][Full Text] [Related]
13. The 22K variant of rat prolactin: evidence for identity to prolactin-(1-173), storage in secretory granules, and regulated release.
Anthony PK; Stoltz RA; Pucci ML; Powers CA
Endocrinology; 1993 Feb; 132(2):806-14. PubMed ID: 8425495
[TBL] [Abstract][Full Text] [Related]
14. Effects of bromocriptine on serum prolactin levels, pituitary weight and immunoreactive prolactin cells in estradiol-treated ovariectomized rats: an experimental model of estrogen-dependent hyperprolactinemia.
Ribeiro MF; Spritzer PM; Barbosa-Coutinho LM; Oliveira MC; Pavanato MA; Silva IS; Reis FM
Braz J Med Biol Res; 1997 Jan; 30(1):113-7. PubMed ID: 9222412
[TBL] [Abstract][Full Text] [Related]
15. Restoration by bromocriptine of glucocorticoid receptors and glucocorticoid negative feedback on prolactin secretion in estrogen-induced pituitary tumors.
Piroli G; Grillo C; Ferrini M; Diaz-Torga G; Libertun C; De Nicola AF
Neuroendocrinology; 1993 Sep; 58(3):273-9. PubMed ID: 8255389
[TBL] [Abstract][Full Text] [Related]
16. Estrogen-induced hyperplasia and neoplasia in the rat anterior pituitary gland. An immunohistochemical study.
Lloyd RV
Am J Pathol; 1983 Nov; 113(2):198-206. PubMed ID: 6638150
[TBL] [Abstract][Full Text] [Related]
17. The effect of bromocriptine on the mammary glands of hyperprolactinemic rats. A histologic, ultrastructural and morphometric study.
Murray IC; McComb DJ; Hellmann P; Kovacs K; Thorner MO
Exp Pathol; 1984; 26(3):131-40. PubMed ID: 6542869
[TBL] [Abstract][Full Text] [Related]
18. In vivo supersensitivity of the anterior pituitary of old female rats to dopaminergic inhibition of prolactin secretion.
Cocchi D; Novelli A; Ganzetti I; Müller EE
Gerontology; 1984; 30(6):345-9. PubMed ID: 6519436
[TBL] [Abstract][Full Text] [Related]
19. Alteration of the mammotroph Golgi complex by the dopamine agonist 2 Br-alpha-ergocryptine (CB-154) in ovariectomized estrogen primed rats.
Poole MC; Easley CS; Hodson CA
Anat Rec; 1991 Nov; 231(3):339-46. PubMed ID: 1763815
[TBL] [Abstract][Full Text] [Related]
20. Targeted overexpression of galanin in lactotrophs of transgenic mice induces hyperprolactinemia and pituitary hyperplasia.
Cai A; Hayes JD; Patel N; Hyde JF
Endocrinology; 1999 Nov; 140(11):4955-64. PubMed ID: 10537119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
